Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.
Journal: Nature medicine
Published: August 07, 2024
Patient with Lobular Carcinoma of the Breast and Activating AKT1 E17K Variant.
Journal: Acta medica academica
Published: February 24, 2021
Showing 1-3 of 3
Last Updated: 09/26/2026